I mentioned this one yesterday for those interested in the contarian approach. ie biotechs have not exactly been doing well lately. This is the best time to buy of course. The question with biotechs given the long lead time and great risk is which one. It's a bit of a lottery in all honesty but I bought into ANX recently after looking closely at them. It will take a while but I believe they have potential.
Chuck
ANADIS LIMITED 2002-06-05 ASX-SIGNAL-G
HOMEX - Melbourne
+++++++++++++++++++++++++
Anadis scientists have demonstrated a new technique, tentatively
titled "Bioshielding", for delivering delicate molecules (such as
vaccines and pharmaceuticals) to the stomach wall. This technology is
an important breakthrough achieved through our work with H pylori
vaccines. The applications for this technology has benefits not only
for Anadis' products currently in development but also for a wide
range of existing products needing to be delivered to the
gastrointestinal tract in an active state.
Preserving delicate molecules such as vaccine proteins to target the
stomach wall has been impossible in the past because of the
aggressive acid and digestive enzymes present which destroy any
delicate molecule before it reaches its target. This breakthough
means that direct drug treatment of the stomach lining is now
possible. Many products that may have been shelved in the past by
other drug developers because they were too delicate to survive the
harsh environment around the stomach lining may now reach commercial
reality.
Anadis has lodged a provisional patent covering the work done to date
and is actively pursuing further research to expand other
applications for this platform technology. As new applications for
the technology are created Anadis will further define the existing
patent or lodge further patents for this discovery.
C Graham
MANAGING DIRECTOR & CEO
For further information Contact:
Conor Graham or Dr Grant Rawlin
Telephone: 03 93586388
Facsimile: 03 93586399
Email: [email protected]
ANX
anadis limited